1. Home
  2. TECX vs HQ Comparison

TECX vs HQ Comparison

Compare TECX & HQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$19.69

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Horizon Quantum Holdings Ltd. Class A Ordinary Shares

HQ

Horizon Quantum Holdings Ltd. Class A Ordinary Shares

N/A

Current Price

$14.10

Market Cap

674.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
HQ
Founded
2019
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
674.1M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
TECX
HQ
Price
$19.69
$14.10
Analyst Decision
Strong Buy
Buy
Analyst Count
10
2
Target Price
★ $71.00
$20.50
AVG Volume (30 Days)
★ 182.1K
94.7K
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.70
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.60
$8.29
52 Week High
$39.53
$45.00

Technical Indicators

Market Signals
Indicator
TECX
HQ
Relative Strength Index (RSI) 30.40 45.79
Support Level $16.77 $13.68
Resistance Level $22.44 $14.43
Average True Range (ATR) 1.08 1.11
MACD 0.16 0.06
Stochastic Oscillator 4.51 47.94

Price Performance

Historical Comparison
TECX
HQ

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About HQ Horizon Quantum Holdings Ltd. Class A Ordinary Shares

Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.

Share on Social Networks: